Alex Badamchi-Zadeh

Experience

1. Stealth Immunology BiotechInvestorcurrent2026 — presentSan Francisco Bay Area
2. Stealth Migraine BiotechInvestor Board Director & Founding Teamcurrent2025 — presentLondon Area, United Kingdom
3. Dualitas TherapeuticsInvestor Board Observer & Founding Teamcurrent2022 — presentSan Francisco Bay Area
4. Cancer Research UK (CRUK)Investment Committee Member (Cancer Research Horizons)current2022 — presentLondon Area, United Kingdom
5. Nimbus TherapeuticsInvestorcurrent2022 — presentCambridge, Massachusetts, United States
6. Alchemab Therapeutics LtdInvestor Board Observercurrent2020 — presentCambridge, England, United Kingdom
7. SitryxInvestorcurrent2020 — presentOxford, England, United Kingdom
8. SV Health InvestorsBiotech Investorcurrent2020 — presentGreater London, England, United Kingdom
9. BioAge LabsInvestor2024 — 2026San Francisco Bay Area
10. EyeBioInvestor Board Observer & Founding Team2021 — 2024London Area, United Kingdom
11. Therini Bio, Inc.Investor2022 — 2024
12. Catamaran BioInvestor2022 — 2024
13. TRexBioInvestor2020 — 2023
14. Xilio Therapeutics, Inc.Business Development & Strategy2018 — 2020Cambridge, Massachusetts
15. L.E.K. ConsultingLife Sciences Specialist Consultant2017 — 2018Boston, Massachusetts
16. Harvard Medical SchoolPostdoctoral Fellow2014 — 2017Brookline, Massachusetts

Education

1. University of OxfordBA (Hons) & MA (Oxon), Christ Church2006 — 2009
2. Imperial College LondonDoctor of Philosophy (PhD), Medicine (Immunology)2011 — 2014
3. Harvard Business SchoolEconomics for Managers; Business Analytics; Financial Accounting2019
4. Imperial College LondonMaster of Research (MRes), Molecular & Cellular Basis of Infection & Immunity2010 — 2011

Skills & more

Languages English

From Alex's professional profile.

Same school

Also attended University of Oxford745

RHReid HoffmanCo-founder of LinkedIn; Partner at GreylockMMMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBGBrad GerstnerFounder & CEO of Altimeter CapitalDJDominic JacquessonInvestor at Index VenturesEPErin Price-WrightInvestor at Index VenturesJHJan HammerInvestor at Index Ventures

+ 739 more

Also attended Imperial College London327

DSDeji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMLMadison LenormandInvestor at DaphniPBPauline BoucherInvestor at DaphniLELoubaba El AyoubiInvestor at NorthzoneGMGiovanni MariggiInvestor at MedicxiFPFrancois PrinslooInvestor at Medicxi

+ 321 more

Also attended Harvard Business School1,818

BGBrad GerstnerFounder & CEO of Altimeter CapitalALAileen LeeFounder & Managing Partner of Cowboy VenturesJBJim BreyerFounder & CEO of Breyer CapitalTDTim DraperFounder of Draper AssociatesMMMike Maples JrCo-founding Partner at FloodgateMHMamoon HamidPartner at Kleiner Perkins

+ 1,812 more

Shared employers

Also worked at Cancer Research UK (CRUK)18

GMGiovanni MariggiInvestor at MedicxiDSDominic SchmidtGeneral Partner at Advent Life SciencesMCMilenko CicmilVenture Partner at Cure VenturesMTMartin TaylorPrincipal at F-Prime Capital PartnersSHSophie HughesInvestment Analyst at Seroba Life SciencesCFCalum ForsythInvestor at Techstart Ventures

+ 12 more

Also worked at Nimbus Therapeutics5

EMErin MooreInvestor at Third Rock VenturesJKJeb KeiperInvestor at Third Rock VenturesRKRosana KapellerInvestor at GV (Google Ventures)LSLaura StoppelPartner at RA CapitalBGBrian GallagherPartner at SR One Capital Management

Also worked at BioAge Labs4

VPVijay PandeGeneral Partner, Andreessen Horowitz at Propagator VenturesTETõnu EskoVenture Partner and Scientific Advisor at Specialist VCCMColin MaraganorePartner at Bija VenturesMAMedha AgarwalPartner at Redpoint Ventures

Also worked at Xilio Therapeutics, Inc.5

DLDaniel LynchInvestor at GV (Google Ventures)NBNessan BerminghamInvestor at Khosla VenturesKGKeno GutierrezGeneral Partner at BioGeneration VenturesPDPeter DudekPresident at MRL Ventures FundUEUgur EskiocakFounder / EIR at 82VS